Roche Partners with Recursion AI to Discover Brain Disease Targets

Roche is collaborating with Recursion AI, leveraging artificial intelligence to identify new targets for brain diseases, aiming to reduce the number of failed drug trials.

6 Aug, 10:30 — 6 Aug, 10:30

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh11h ago

Roche Uses Recursion AI to Uncover New Brain Disease Targets

A new generation of AI companies believes it can reduce the number of failed drug trials.

By Fabienne Kinzelmann

Read full article →

PERSPECTA

PERSPECTA

Roche Partners with Recursion AI to Discover Brain Disease Targets

Sources

Roche Uses Recursion AI to Uncover New Brain Disease Targets

Related Stories

StandardAero and Cognition Therapeutics Report Earnings

AMD Acquires Taalas to Boost AI Inference Capabilities

Lyell Immunopharma and Cable One Announce Q2 Earnings

Somnigroup and LTC Announce Future Financial Targets and Acquisition Plans

PERSPECTA